A scoping review found that liquid biopsy offers a dynamic measure of tumor biology that complements pathological staging and guides postoperative management beyond conventional anatomy-based risk stratification. (Updates in Surgery)
Liquid biopsy may redefine surgical decision-making in colorectal cancer
The CRC Digest